Back to Research Hub
Atai Beckley N.V
ATAI
$3.89+0.08 (+2.10%)
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
StreetsValue research for Atai Beckley N.V (ATAI)
Members get the full report for Atai Beckley N.V: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.